Goff Brian (CIK 1546216) reported 26 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-10). Recent activity: Buy NTLA (9,200 shares), Buy AGIO (25,528 shares), Sell AGIO (12,472 shares), Buy AGIO (13,500 shares), Sell AGIO (6,596 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | Intellia Therapeutics, Inc. (NTLA) | Director | Buy | 9,200 | $0 |
| 2026-04-06 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 25,528 | $0 |
| 2026-04-06 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 12,472 | $432,903 |
| 2026-04-06 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 13,500 | $0 |
| 2026-04-06 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 6,596 | $228,947 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 8,500 | $0 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 3,870 | $112,075 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 18,000 | $0 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 8,267 | $239,412 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 13,000 | $0 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 5,918 | $171,385 |
| 2026-01-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 12,473 | $337,894 |
| 2026-01-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 25,528 | $0 |
| 2026-01-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 12,750 | $0 |
| 2026-01-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 6,230 | $168,771 |
| 2025-08-12 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 22,691 | $0 |
| 2025-08-12 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 11,085 | $406,487 |
| 2025-06-26 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 25,527 | $0 |
| 2025-06-26 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 12,471 | $418,277 |
| 2025-06-26 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 12,750 | $0 |
| 2025-06-26 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 6,229 | $208,921 |
| 2025-06-13 | Intellia Therapeutics, Inc. (NTLA) | Director | Buy | 8,000 | $0 |
| 2025-03-04 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 8,500 | $0 |
| 2025-03-04 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Sell | 4,153 | $147,598 |
| 2025-03-04 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | Buy | 18,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-10